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Extensive eﬀorts are exerted looking for safe and eﬀective chemotherapy for hepatocellular carcinoma (HCC). Speciﬁc and
sensitive early biomarkers for HCC still in query. Present work to study proteolytic activity and lysosomal membrane integrity
by hepatocarcinogen, trichloroacetic acid (TCA), in Wistar rats against aqueous olive leaf extract (AOLE).TCA showed neoplastic
changes as oval- or irregular-shaped hepatocytes and transformed, vesiculated, and binucleated liver cells. The nuclei were
pleomorphic and hyperchromatic. These changes were considerably reduced by AOLE. The results added, probably for the ﬁrst
time, that TCA-induced HCC through disruption ofhepatocellular proteolytic enzymes as upregulation of papain, free cathepsin-
D and nonsigniﬁcant destabilization of lysosomal membrane integrity, a prerequisite for cancer invasion and metastasis. AOLE
introduced a promising therapeutic value in liver cancer, mostly through elevating lysosomal membrane integrity. The study
substantiated four mainpoints:(1) the usefulness of proteolysis andlysosomalmembraneintegrity in early prediction of HCC. (2)
TCA carcinogenesis is possibly mediated by lysosomal membrane destabilization, through cathepsin-D disruption, which could
be reversed by AOLE administration. (3) A new strategy for management of HCC, using dietary olive leaf system may be a helpful
phytotherapeutic trend. (4) A prospective study on serum proteolytic enzyme activity may introduce novel diagnostic tools.
1.Introduction
The metabolism of functional proteins is a continuous
process involving proteolysis, which is the destruction of
individual protein molecules and their replacement through
protein synthesis. Intracellular proteolysis includes either
lysosomal (cathepsins) or nonlysosomal pathway, which is
mostly executed by calpains and proteasomes [1–3]. The
rate of degradation of both intracellular and extracellular
proteins is greatly dependent on cathepsin activity.
The degradation rate of proteins can be monitored by
measuring cathepsin activity oscillations [4]. Lysosomes are
membrane-bound structures containing hydrolytic enzymes
capable of degrading most of the cellular constituents. They
also play a pivotal role in secretion and transport processes.
Leakage of lysosomal enzymes accounts for many tissue
derangementsandtargetorganopathies [5,6].Lysosomes are
found in all animal cells and are more numerous in disease-
ﬁghting cells.
Lysosomalenzymedisorderscontributetoseveralhuman
diseases, either due to genetic defects in its enzyme
expression or the escape of lysosomal enzymes (lysozymes)
into extralysosomal medium [7]. Hepatocellular carcinoma
(HCC) is considered as one of the worst prognostic can-
cers in the world. It develops mostly over chronic liver
diseases of cirrhotic fate. HCC nodules are always encap-
sulated by excessive extracellular matrix (ECM) materials
among a bed of cirrhotic tissue [8, 9]. ECM degradation
by speciﬁc proteases was reported to play an impor-
tant role in cancer invasion and metastasis [10]. It was
noticed that some herbals could ameliorate anticancer-
induced lysosomal abnormalities, conserving lysosomal
integrity, probably, through an antioxidant mechanism
[6].
Studies of the trichloroethylene (TCE) metabolites,
dichloroacetic acid (DCA), trichloroacetic acid (TCA), and
chloral hydrate suggested that both DCA and TCA are
involved in TCE-induced liver tumorigenesis and that many2 International Journal of Hepatology
DCA eﬀects are consistent with conditions that increase the
risk of liver cancer [11–13].
Olive tree (Olea europaea, Oleaceae) is a longevous
plant, anciently known in the Mediterranean basin [14].
Olive leaves are rich in active constituents showing medic-
inal value. They possess many water-soluble compounds
of antioxidant and anti-inﬂammatory properties [15].
The most important bioactive compounds are oleuropein
(13.4%) and rutin (0.18%), luteolin-7-glucoside, verbasco-
side, apigenin-7-glucoside, hydroxytyrosol, and some other
hydrolytic products, both of glycosidic and ﬂavonoid nature
[16, 17]. The leaves also contain many terpenoids hav-
ing hepatoprotective and cancer-preventive potential [18].
Besides, Guinda et al. [19] had described many liposoluble
principles in olive leaf, as squalene, carotenoid, vitamin E,
alcohols, and saturated hydrocarbons. Many other ingredi-
ents were studied in olive leaf of diﬀerent medicinal and
nutritional values [20]. It is now established that olive
polyphenols exert chemopreventative eﬀects in the large
intestine by interacting with signaling pathways responsible
for colorectal cancer development [21]. The present work
was executed to explore the possible therapeutic value of
an aqueous extract of olive leaves which possess polyphe-
nolic ﬂavonoids, taking into account the cost-eﬀectiveness
of olive leaves as a nonordinarily utilized part and to
try its eﬃcacy in hepatocarcinoma treatment, through
monitoring the early variations in liver tissue proteolytic
activity, as speciﬁc enzyme, pepsin, trypsin, papain, and
cathepsin enzyme activities. The total/free cathepsin activity




2.1.1. Animals. Male Wistar rats weighing 190 ± 10g were
used in this experiment. These rats were given ordinary
rodent diet and water ad libitum. They were housed in
polyethylenecagesinahumidroomwithcontrolled12hours
light and 12 hours dark cycle. They were classiﬁed into 4
groups (8rats/group).
2.1.2. Chemicals. All chemicals were supported from local
suppliers, all were of analytical grade. Tyrosine was pur-
chased from Merck.
2.1.3. Aqueous Olive Leaves Extract (AOLE). It was kindly
givenbyDr.AshrafEl-Bassiouny, NaturalProductChemistry
Department, Institute of Education and Science, Beni Suef
University, Egypt. It was prepared by drying for 8 hours, at
40◦C, water-washed fresh olive leaves collected on February
of 2007, milled, homogenized and then extracted by heating
with distilled water with stirring at 40◦Cf o r4 8h o u r sa s
10g powder of dried leaves/60 CC solvent, cooled, ﬁltered,
and the supernatant was kept at 4◦C during the period of
administration [22].Thisextract isdark-green in color,clear,
fragrant, and has a little sweet taste.
2.1.4. Drug Administration Schedules per Groups. The ﬁrst
group of rats served as control, in which animals were given
0.5ml physiological saline by intraperitoneal route (IP),
daily,for one month.The second groupservedas livercancer
group, given a daily IP dose of trichloroacetic acid (TCA)
(Sigma-Aldrich, USA), for 5 consecutive days, by gavage
as 500mg/kg body weight, previously dissolved in distilled
water,neutralizedbyNaOHtoapHof5–7.5[23].Animalsof
the third group were given AOLE (softened by drying under
vacuum) by gavage in a single daily dose for one month
as 0.5g/kg body weight [24]. This group was considered as
positive drug control.
Animals of group four were given doses of TCA for
5 consecutive days, 24 hours after the last dose, AOLE
doses were given as stated before. Twenty-four hours after
each dosing period, animals were killed, livers were excised,
washed with saline, frozen directly into liquid nitrogen
and kept frozen at −80◦C right at the day of analytical
investigations.
2.2. Methods. (1) Extractionof the target enzymes from liver
tissue: 300mg of liver tissue was homogenized with 6ml ice-
cold distilled water as described elsewhere [25]. Total protein
was determined in each enzyme substrate prior to enzyme
assessment, by the method Lowry et al. [26].
(2) Determination of speciﬁc proteolyticenzyme activity
was achieved in the tissue extract on a substrate containing
1% egg albumin as the substrate protein for enzyme actions
[27]. Colorimetric estimation of tyrosine, as the product of
proteolysis was conducted by diluted Folin-Ciocalteu (FC)
reagent, [28] against tyrosine standard curve [29].
(3) Estimation of pepsin, trypsin, and papain proteolytic
activity was accomplished through changing the pH of the
protein substrate per each target enzyme as stated by Anson
[27], then, tyrosine was estimated as mentioned earlier [25,
29].
(4) Estimation of lysosomal membrane integrity: this
variable relied on determination of cathepsin proteolytic
activity in the tissue extract by acidifying the protein
substrate (free cathepsin-D activity) and after dilution of the
extract, then, frequent cycles of freezing and thawing were
applied(totalcathepsin-D activity) [30–33].Enzyme activity
in all cases was considered as µg-released tyrosine/mg sub-
strate protein. Total/free cathepsin D activity was considered
as a measure of lysosomal membrane integrity [31, 32].
(5) Statistical analysis: the presented data were expressed
as mean ± SE. Statistical signiﬁcance was examined by
one-way analysis of variance (ANOVA), [34]. P values less
than .05 were assumed to be statistically signiﬁcant.
(6) Liver samples were stained by Hematoxylin and
Eosin, examined microscopically to follow tissue changes in
response to TCA and AOLE therapy.
3.Results
TCA administration showed loss of normal architecture
with oval- or irregular-shaped hepatocytes. Many trans-
formed liver cells of foci were substantially enlarged, largely
vesiculated and frequently binucleated, which were clearlyInternational Journal of Hepatology 3
Figure 1: Liver section in control animals showing normal paren-
chymal cells with granulated cytoplasm and normal architecture.
(a)
(b)
Figure 2: TCA-treated rats showing loss of normal architecture
with oval- or irregular-shaped hepatocytes, denser nuclear chro-
matin,the ratio ofnucleus to cytoplasm was increased, many trans-
formed liver cells were frequently binucleated and hyperchromatic
(basophilic).
distinguishable from the surrounding normal parenchyma.
The nuclei were mostly found to be pleomorphic and hyper-
chromatic. These changes were reduced by the treatment
with AOLE (Figures 1, 2, 3,a n d4).
The biochemical results of the experiment are summa-
rized in Table 1. As shown, TCA treatment signiﬁcantly
upregulated both papain and free cathepsin-D and non-
signiﬁcantly elevated speciﬁc enzyme, pepsin, trypsin, and
Figure 3:LiversectioninAOLE-treated ratsshowsanormalcentral
vein and blood sinusoids.
Figure 4: Liver section in TCA- and AOLE-treated rats showing
a moderate improvement in hepatocellular structure, evidenced
as a moderate improvement in vacuolation and compactness of
hepatocytes compared to TCA-treated group but dilated sinusoids
are still present.
total cathepsin-D activities, with nonsigniﬁcant reduction of
lysosomal membrane integrity.
Administration ofAOLEalonedidnotsigniﬁcantlyaﬀect
the studied variables, but only signiﬁcantly upregulated
papain activity. Treatment of TCA-injured rats with AOLE
signiﬁcantly elevated trypsin and papain, with reduction of
pepsin activities. It signiﬁcantly decreased free cathepsin-D
activity, leading to signiﬁcant increase in lysosomal integrity
index.
4.Discussion
Lysosomal proteolytic activity in liver cells plays a decisive
role in protein metabolism, with cathepsin-A and cathepsin-
D being the main enzymes involved in catabolic processes
[35]. Tumor cells require speciﬁc proteolytic enzymes for
invasion and metastasis, including lysosomal peptidases-
cathepsin [36].
Recently, it was noticed that proteases play a critical
role not only in tumor cell invasion, but also in the
earliest stages of carcinogenesis and its associated changes:
angiogenesis and metastasis. Proteases are also signaling
molecules that modulate other molecules by underlying
pathways in addition to their degradative role [37].4 International Journal of Hepatology
Table 1: Proteolytic enzyme activities (µg-released tyrosine/mg substrate protein) and lysosomal integrity (total/free cathepsin-D activity)
inlivertissueofratstreated by aqueousoliveleafextract (foronemonth)aftertrichloroacetic acidcarcinogenicchallenge(for5days).Values
are expressed as mean ± S.E (N = 8).
Group
Parameter Control TCA (500mg/kg) AOLE (500mg/kg) TCA + AOLE (500mg/kg + 500mg/kg)
Speciﬁc enzyme activity 24.2 ± 0.55 24.9 ± 0.32 24.4 ± 0.39 24.7 ±0.3
Pepsin activity 15.5 ± 0.13 15.8 ± 0.13 15.3 ± 0.13 12.3
∗∗ ±0.25
Trypsin activity 11.3 ± 0.31 1 .9 ± 0.21 1 .4 ± 0.61 3 .3
∗∗ ±0.2




Free cathepsin-D activity 5.1 ± 0.16 .2
∗∗ ±0.25 .5 ± 0.24 .5
∗ ±0.1
Total cathepsin-D activity 3.6 ±0.13 4 ±0.05 4 ±0.05 4.4
∗∗ ±0.04
Lysosomalintegrity 0.72 ± 0.03 0.65 ± 0.02 0.74 ± 0.03 0.99
∗∗ ±0.04
∗Signiﬁcantlydiﬀerent from control at ∗∗P<. 05. Signiﬁcantlydiﬀerent from control at P<. 01.
In the present work, TCA treatment depicted non-
signiﬁcant upregulations in speciﬁc enzyme, pepsin, trypsin,
and total cathepsin-D activities, with decrease in lysosomal
integrity; however, it signiﬁcantly activated both papain
and free cathepsin-D activity. Speciﬁc proteolytic enzymes,
includingendopeptidasesarenecessary prognosticindicators
(prognosticators) after tumor resection. They always rise up
in patients at risk of recurrence [38]. TCA is one of three
metabolites of trichloroethylene, a common solvent known
classically to pollute groundwater. They are nongenotoxic
carcinogens [23]. TCA is also considered as a member of
peroxisome proliferators, responsible for many mutations,
leading to diverse-target organ cancers [3].
This early upregulatory impact of TCA on proteolytic
enzymes may contribute to the mechanism of cancer induc-
tion and invasion by this substance, an action that was
noticed in some previous publications [39, 40]. Adminis-
tration of AOLE alone maintained some proteolytic enzyme
activities within normal values, exceptan elevationofpapain
activity to a signiﬁcant level. The modulatory action on both
totaland free cathepsin-Dactivities couldpreservelysosomal
membrane integrity, thus protecting cellular biomolecules.
This lysosomal-stabilizing potential of AOLE is mostly
referred to its potent antioxidant and anti-inﬂammatory
properties [16].
It is clear in these results that disruption of lysosomes
will lead to increased proteolytic activity, while preservation
will keep cellular components and protect against neoplastic
invasiveness [41]. In addition, AOLE, when given after TCA
challenge, corrected the proteolytic action and restabilized
lysosomal membrane to a signiﬁcant value. It seems that the
main therapeutic pathway for this leaf extract is mediated
by pepsin and cathepsin-D variation in favour of lysosomal
membrane stabilization. It is well established that cancer can
induce enzyme synthesis to an extent of leakage into peri-
cellular components [42]. However, addition of AOLE may
induce increased proteolytic enzymes that might hydrolyse
angiogenic proteins useful for de novo cancer progression
[37].
The use of olive leaves introduces supplementary treat-
ment in cancer management, instead of cytotoxicity and
cytodestructioninduced by chemotherapeutic agents. It may
modulate the cellular phenotypic characteristics atend-stage
of adult cells leading to programmed cell death (apoptosis)
[43].Recentstudyprovedthe usefulness ofolive leaveextract
in inhibition of diﬀerentiation of human leukemia cell line
[44].
It can be concluded that olive leaf consumption has
health beneﬁts in favouring liver cancer management. It
can be recommended as a dietary supplement during
liver cancer management and even after cancer protocol is
stopped to guarantee recurrence. TCA can be considered as
a carcinogen of proteolytic potential, by which it initiates
hepatocarcinoma. Early changes in lysosomal membrane
integrity, manifested by increased release of proteases may
add a new line of research to ﬁgure out more speciﬁc and
sensitive early biomarkers as diagnostic tools. This change
in proteolytic activity necessitates further studies on blood
to assess a possible escape of these studied enzymes into
circulation.This may contributetoa new trend, bothin early
HCC assessment and prognosis.
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